# Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)

> **NCT00146978** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 50 (—)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **PROCEDURE:** intra-arterial treatment

## Key facts

- **NCT ID:** NCT00146978
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146978, "Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00146978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*